Literature DB >> 32485574

Lipase Inhibitors for Obesity: A Review.

Tian-Tian Liu1, Xiao-Tian Liu1, Qing-Xi Chen1, Yan Shi2.   

Abstract

With the rapid increase in the population of obese individuals, obesity has become a global problem. Many kinds of chronic metabolic diseases easily caused by obesity have received increasing attention from researchers. People are also striving to find various safe and effective treatment methods as well as anti-obesity medicines. Pancreatic lipase (PL) inhibitors have received substantial attention from researchers in recent years, and PL inhibitors from natural products have attracted much attention due to their structural diversity, low toxicity and wide range of sources. They have been used in the intestinal tract, blood, and the central nervous system with no side effects, and these advantages could lead to a new generation of diet pills or health care products with great development potential. This article is mainly aimed at discussing the research of obesity drug treatment with PL inhibitors and offers a brief review of related properties and the use of PL inhibitors in the field of weight loss.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  lipase inhibitor; lipid metabolism; natural product; obesity

Mesh:

Substances:

Year:  2020        PMID: 32485574     DOI: 10.1016/j.biopha.2020.110314

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  28 in total

Review 1.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

2.  Amelioration of hyperglycemia and hyperlipidemia in a high-fat diet-fed mice by supplementation of a developed optimized polyherbal formulation.

Authors:  Sunil Venkategowda; Mala Majumdar
Journal:  3 Biotech       Date:  2022-08-30       Impact factor: 2.893

Review 3.  Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.

Authors:  Yang Yang; Myah Trevethan; Shu Wang; Ling Zhao
Journal:  J Nutr Biochem       Date:  2022-02-18       Impact factor: 6.117

4.  Novel Oxazine Monoacylglycerol Lipase (MAGL) Inhibitors.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-02-04       Impact factor: 4.345

5.  Heterocyclic Compounds as Monoacylglycerol Lipase (MAGL) Inhibitors.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-03-31       Impact factor: 4.345

Review 6.  Therapeutic Potential of Hispidin-Fungal and Plant Polyketide.

Authors:  Kseniia A Palkina; Daria A Ipatova; Ekaterina S Shakhova; Anastasia V Balakireva; Nadezhda M Markina
Journal:  J Fungi (Basel)       Date:  2021-04-22

7.  A mixture of poly-γ-glutamic acid and levan ameliorates obesity in high fat diet-induced mice.

Authors:  Ki-Hyo Jang; Mi-Ja Kim
Journal:  Food Sci Biotechnol       Date:  2022-02-25       Impact factor: 2.391

Review 8.  Pharmacological and Antioxidant Activities of Rhus coriaria L. (Sumac).

Authors:  Halima Alsamri; Khawlah Athamneh; Gianfranco Pintus; Ali H Eid; Rabah Iratni
Journal:  Antioxidants (Basel)       Date:  2021-01-08

9.  A network pharmacology study on main chemical compounds from Hibiscus cannabinus L. leaves.

Authors:  Ki Kwang Oh; Md Adnan; Inseok Ju; Dong Ha Cho
Journal:  RSC Adv       Date:  2021-03-17       Impact factor: 3.361

10.  The gut commensal fungus, Candida parapsilosis, promotes high fat-diet induced obesity in mice.

Authors:  Shanshan Sun; Li Sun; Kai Wang; Shanshan Qiao; Xinyue Zhao; Xiaomin Hu; Wei Chen; Shuyang Zhang; Hantian Li; Huanqin Dai; Hongwei Liu
Journal:  Commun Biol       Date:  2021-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.